Humana’s (HUM) Outperform Rating Reiterated at Royal Bank of Canada

Humana (NYSE:HUM)‘s stock had its “outperform” rating reissued by analysts at Royal Bank of Canada in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $283.00 price target on the insurance provider’s stock. Royal Bank of Canada’s target price would suggest a potential upside of 8.30% from the company’s previous close.

Several other brokerages have also weighed in on HUM. Morgan Stanley reduced their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday. TD Cowen boosted their price objective on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Truist Financial increased their target price on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Wells Fargo & Company dropped their price target on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Finally, Barclays boosted their target price on shares of Humana from $253.00 to $255.00 and gave the company an “equal weight” rating in a report on Wednesday, January 22nd. Nineteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Humana currently has an average rating of “Hold” and an average price target of $292.26.

Humana Stock Performance

Shares of HUM traded up $3.97 on Wednesday, reaching $261.31. 1,014,058 shares of the company’s stock traded hands, compared to its average volume of 1,631,401. The stock’s 50 day simple moving average is $273.00 and its two-hundred day simple moving average is $295.72. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana has a 52-week low of $213.31 and a 52-week high of $406.46. The stock has a market cap of $31.46 billion, a PE ratio of 23.22, a PEG ratio of 2.11 and a beta of 0.56.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, analysts forecast that Humana will post 16.11 earnings per share for the current fiscal year.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.32% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. FNY Investment Advisers LLC lifted its holdings in shares of Humana by 6,647.5% during the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after buying an additional 26,856 shares during the period. Retirement Systems of Alabama grew its holdings in Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after purchasing an additional 192,801 shares during the period. PDT Partners LLC raised its position in shares of Humana by 190.0% during the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after purchasing an additional 2,660 shares during the period. Secure Asset Management LLC purchased a new stake in Humana in the 4th quarter worth $244,000. Finally, Ontario Teachers Pension Plan Board increased its holdings in shares of Humana by 6.5% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after purchasing an additional 71,910 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.